Skip to Content

Enhancing US Life Expectancy in 2022 Despite Surge in Child Deaths and Record High Drug Overdoses

In 2022, the United States witnessed a positive upturn in life expectancy, marked by a decline in death rates attributed to Covid-19 and other primary causes. Despite this improvement, there was a concerning surge in child mortality rates and a record number of deaths resulting from drug overdoses.

The final report released by the US Centers for Disease Control and Prevention revealed a notable 1.1-year rise in overall life expectancy, reaching 77.5 years at birth. However, this increment only mitigated less than half of the 2.4-year life expectancy reduction experienced during the initial phase of the Covid-19 pandemic. Consequently, the current life expectancy remains below levels observed over the past two decades.

The Covid-19-related death rate saw a significant decrease of over 50% from 2021 to 2022, contributing to a 9% overall decline in mortality rates. Although Covid-19 transitioned from the third to the fourth leading cause of death, it still accounted for more than 186,000 fatalities, representing approximately 6% of total deaths in the US for 2022.

Despite the positive trajectory, heart disease retained its position as the primary cause of death in the US, followed closely by cancer according to the latest CDC data. While both heart disease and cancer reported a slight decrease of around 4% and 3% in death rates, collectively, they continued to be responsible for 40% of all deaths nationwide.

Dr. Steven Woolf, Director Emeritus of the Virginia Commonwealth University Center on Society and Health, emphasized the significance of life expectancy as a barometer of population health. He highlighted the favorable impact of widespread vaccination against Covid-19 in reducing mortality rates, alongside the resumption of regular medical care for chronic conditions, reflecting the rebound in life expectancy figures.

However, despite these improvements, the US lags behind peer nations in life expectancy, a trend persisting for several decades. Dr. Woolf underscored that the lower life expectancy in 2022 compared to 2019 indicates ongoing challenges, with Americans facing higher mortality rates post-pandemic.

Of particular concern is the notable increase in child mortality rates, with a 12% rise among children aged 1 to 4 and a 7% increase for those aged 5 to 14 in 2022. This alarming trend, alongside a rise in infant mortality, raises significant apprehensions about the well-being of American children and their prospects of reaching adulthood.

Moreover, the escalating mortality rates among children and adolescents, attributed to causes such as homicides, suicides, drug overdoses, and accidents, pose a threat to the progress made in reducing pediatric mortality rates. The prevalence of drug overdoses, accounting for a substantial portion of accidental deaths, underscores the persistent challenges posed by the drug epidemic, with 2022 registering the highest number of drug-related fatalities on record.

The complexity of factors driving the overdose epidemic necessitates comprehensive interventions to reverse the rising death toll. While the Covid-19 crisis may have exacerbated existing challenges, it also presents opportunities to enhance service delivery and support mechanisms. Efforts to scale up evidence-based interventions and improve accessibility to care are crucial in mitigating the adverse impacts of drug-related harm on individuals and communities.

Noteworthy disparities in overdose death rates across demographic groups were observed, with specific increases among certain racial and ethnic populations. The prevalence of synthetic opioids, particularly fentanyl, and the spike in cocaine and psychostimulant-related deaths underscore the evolving landscape of substance-related fatalities in the US.

In conclusion, the 2022 mortality trends in the United States reflect a nuanced interplay of factors influencing life expectancy and mortality rates, underscoring the imperative for targeted interventions to address the challenges posed by Covid-19, drug overdoses, and child mortality.